tiprankstipranks
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
Holding ELDN?
Track your performance easily

Eledon Pharmaceuticals (ELDN) Financial Statements

787 Followers

Eledon Pharmaceuticals Financial Overview

Eledon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.71; its P/E ratio is -0.68; Eledon Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 76.97M$ -44.91M$ -10.29M$ -9.63M$ -11.20M
EBITDA$ 77.05M$ -44.81M$ -10.20M$ -9.53M$ -11.10M
Net Income Common Stockholders$ 54.43M$ -44.91M$ -10.29M$ -9.63M$ -10.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.19M$ 83.61M$ 42.86M$ 51.10M$ 59.61M
Total Assets$ 114.58M$ 120.48M$ 80.82M$ 89.07M$ 96.07M
Total Debt$ 501.00K$ 655.00K$ 284.00K$ 383.00K$ 479.00K
Net Debt$ -77.69M$ -82.95M$ -42.58M$ -50.72M$ -59.13M
Total Liabilities$ 38.52M$ 128.98M$ 6.00M$ 5.65M$ 4.73M
Stockholders Equity$ 76.06M$ -8.50M$ 74.82M$ 83.42M$ 91.33M
Cash Flow-
Free Cash Flow$ -11.78M$ -7.76M$ -8.74M$ -9.13M$ -12.25M
Operating Cash Flow$ -11.78M$ -7.76M$ -8.74M$ -9.13M$ -12.25M
Investing Cash Flow$ -12.80M$ -19.91M$ 9.78M$ 10.08M$ -25.03M
Financing Cash Flow$ 5.28M$ 48.07M$ 1.00K--
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

Eledon Pharmaceuticals Debt to Assets

Eledon Pharmaceuticals Cash Flow

Eledon Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis